cell therapy setback
![2seventy bio, cell therapy, Cell & Gene Therapy, layoffs, sickle cell disease, beta-thalassemia, cell therapy setback, 2seventy bio layoffs](https://pharmtales.com/wp-content/uploads/2023/09/2seventy-Bio-slashes-176-jobs-and-looks-for-new-CEO-after-cell-therapy-setback.jpg)
2seventy Bio slashes 176 jobs and looks for new CEO after cell therapy setback
Anika Sharma
2seventy bio, the spinoff from bluebird bio, is undergoing significant changes under the leadership of CEO Nick Leschly. The company ...